Key Insights

Highlights

Treatment Research

5 treatments under study, led by Questionnaire Administration

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05411107Phase 2WithdrawnPrimary

Oral Iloprost for the Prevention of Lung Cancer In Former Smokers

Showing all 1 trials

Research Network

Common Treatments

  • Questionnaire Administration1
  • Biospecimen Collection1
  • Bronchial Brush Biopsy1
  • Bronchoscopy1
  • Iloprost1

Active Sponsors

  • National Cancer Institute (NCI)1

Top Investigators

Related Conditions

  • Tobaccorelated Carcinoma1
  • Lung Carcinoma1
  • Stage Ii Lung Cancer Ajcc V81
  • Chronic Obstructive Pulmonary Disease1
  • Stage I Lung Cancer Ajcc V81

Activity Timeline